Trials / Sponsors / Definium Therapeutics US, Inc.
Definium Therapeutics US, Inc.
Industry · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 2A Trial of DT402 for Autism Spectrum Disorder Autism Spectrum Disorder, ASD | Phase 2 | 2025-12-03 |
| Active Not Recruiting | A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge) Major Depressive Disorder | Phase 3 | 2025-04-14 |
| Recruiting | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) Generalized Anxiety Disorder | Phase 3 | 2025-01-29 |
| Recruiting | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) Generalized Anxiety Disorder | Phase 3 | 2024-12-11 |
| Completed | A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms Anxiety Generalized | Phase 2 | 2022-08-24 |
| Completed | Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial ADHD, Attention Deficit Disorder | Phase 2 | 2021-12-17 |
| Completed | A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers Addiction | Phase 1 | 2020-04-14 |